These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5157710)

  • 1. [Schizophrenic "terminal stages". Clinic and course].
    Marinow A
    Arch Psychiatr Nervenkr (1970); 1971; 215(1):46-61. PubMed ID: 5157710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, psychopathological and biochemical studies on phenmetrazine psychoses].
    Arnold OH; Hofmann G
    Wien Z Nervenheilkd Grenzgeb; 1969; 27(4):294-305. PubMed ID: 4243713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic pathomorphology during the terminal stages of schizophrenia].
    Vartanian FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):250-7. PubMed ID: 5661308
    [No Abstract]   [Full Text] [Related]  

  • 4. [Features of the course of paroxysmal schizophrenia in advanced age].
    Shesmerneva SE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1362-8. PubMed ID: 5700610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delusional disorders in childhood and adolescent schizophrenia].
    Moiseeva MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):1065-70. PubMed ID: 5368919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Catatonia (1868-1968)].
    Pauleikhoff B
    Fortschr Neurol Psychiatr Grenzgeb; 1969 Sep; 37(9):461-96. PubMed ID: 5195659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Schizophrenic psychoses with meaningful physical findings].
    Alsen V
    Fortschr Neurol Psychiatr Grenzgeb; 1969 Aug; 37(8):448-57. PubMed ID: 5194698
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of schizophrenia: an Anglo-American comparison.
    Edwards G
    Br J Psychiatry; 1972 Apr; 120(557):385-90. PubMed ID: 5040685
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 12. Catatonia: its diagnostic validity.
    Hearst ED; Munoz RA; Tuason VB
    Dis Nerv Syst; 1971 Jul; 32(7):453-6. PubMed ID: 5570414
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of chronic schizophrenias using Valium].
    Baliarda A
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):109-22. PubMed ID: 5801167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lyogen therapy of outcome states in schizophrenia with catatonic symptoms].
    Gorskiĭ GD; Rybakov VL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1575-8. PubMed ID: 5490155
    [No Abstract]   [Full Text] [Related]  

  • 18. Schizophrenic and paranoid disorders in the aged.
    Varner RV; Gaitz CM
    Psychiatr Clin North Am; 1982 Apr; 5(1):107-18. PubMed ID: 6124954
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The course of attack-like schizophrenia with long remission periods].
    Shternberg EIa; Molchanova EK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(1):97-103. PubMed ID: 5020162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.